Smarter Decisions, Healthier Outcomes: The Role of Business Intelligence in Personalized Healthcare

Veritas Automata Saurabh Sarkar

Saurabh Sarkar

Glenda Cherryholmes

Veritas Automata Ed Fullman

Ed Fullman

Today we’ll discuss how Business Intelligence (BI) can harness the power of data to drive better patient outcomes. BI this isn’t your run-of-the-mill data analytics.

No, this is the era of BI infused with IoT devices and AI analytics, where insights are sharp and dynamic. So, let’s dive headfirst into the transformative power of BI in personalized healthcare, where smarter decisions lead to healthier outcomes.

Precision Medicine Unveiled

Picture this: A patient walks into a clinic, not just another name on a chart, but a unique individual with a genetic blueprint, environmental influences, and lifestyle habits as distinct as a fingerprint. Here’s where BI, combined with AI and IoT data, shines bright. Recent studies show that BI can uncover patterns and predict health outcomes with up to 95% accuracy[1]. But why does this matter? Because it enables precision medicine, where treatment plans are as tailored as a bespoke suit, catering to the specific needs of each patient.

Optimizing Operations, Elevating Care

BI isn’t just about improving patient outcomes, it’s also about optimizing healthcare operations from the ground up. Think resource allocation, patient flow management, and operational efficiency dialed up to eleven. By analyzing data trends and operational metrics, BI tools identify bottlenecks, streamline processes, and ensure that every aspect of care delivery runs smoothly.

Proactive Health Management at Your Fingertips
Now, let’s talk about proactive health management – the holy grail of modern medicine. Imagine being able to predict health risks before they even rear their ugly heads, intervening with precision and foresight. By analyzing historical and real-time data, BI tools empower healthcare providers to shift from reactive to proactive and preventive care, keeping patients healthier and happier in the long run.
Financial Planning with a Healthy Bottom Line
But what about the bottom line, you ask? Fear not, because BI has got your back here too. By guiding strategic planning, financial management, and investment decisions, BI analyses ensure that healthcare organizations stay financially fit and thriving. From cost drivers to patient care outcomes to market trends, BI provides the insights needed to navigate the complex landscape of healthcare finance with confidence and clarity.
Empowering Public Health and Research

But the impact of BI doesn’t stop at the clinic door; it extends far beyond, shaping public health policies, driving medical research, and benefiting society as a whole. By aggregating and analyzing data across populations, BI tools uncover health trends, inform policy decisions, and contribute to the advancement of public health initiatives, ensuring a healthier future for all.

Enhanced Patient Engagement, Elevated Experience

Last but certainly not least, let’s talk about the heart of healthcare: patient engagement. By leveraging insights gained from BI analyses, healthcare providers can tailor communication, personalize care plans, and enhance the overall patient experience. From appointment and treatment reminders to communication preferences and lifestyle recommendations, BI ensures that every interaction with the healthcare system is as seamless and satisfying as possible.

So, there you have it – a glimpse into the world of BI in personalized healthcare, where smarter decisions lead to healthier outcomes. From precision medicine to operational optimization, from proactive health management to financial planning, from public health research to patient engagement, BI is the driving force behind a healthcare revolution.

So, the next time you’re faced with a healthcare challenge, remember: with BI by your side, the possibilities are as endless as the data itself.

[1]Ahmad, “AI in Healthcare”

Before the Trial: Using Digital Twins for Preclinical Predictions

Veritas Automata Saurabh Sarkar

Saurabh Sarkar

Veritas Automata Fabrizio Sgura

Fabrizio Sgura

In the high-stakes world of medical research, every trial can be a make-or-break moment.

So we must ask: How can we minimize risks and costs before diving headfirst into clinical trials? Digital Twins! But what’s a Digital Twin, you ask? Well, strap in, because we’re about to take you on a ride through the future of preclinical predictions, where precision meets wit.

The Preclinical Predicament

Imagine this: You’ve poured years of blood, sweat, and caffeine into developing a groundbreaking medical treatment. But before you can even think about human trials, you hit a roadblock. Traditional preclinical testing is like navigating through a foggy maze blindfolded – costly, time-consuming, and fraught with uncertainty. So, how do we break free from this preclinical predicament?

Enter Digital Twins

Digital Twins are the unsung heroes of preclinical predictions. Picture a virtual replica of your treatment, navigating through simulated biological landscapes with the precision of a surgical scalpel. According to recent studies, Digital Twins have been shown to predict treatment responses with up to 90% accuracy. But why should we care about these digital doppelgängers? Well, for starters, they’re about to revolutionize the way we approach preclinical testing.

Minimizing Risks, Maximizing Insights:

Digital Twins offer a sneak peek into the safety and efficacy of treatments before they even hit the clinical trial stage. By harnessing predictive modeling and AI/ML at the edge, researchers can simulate the intricate dance between treatments and biological systems with unparalleled accuracy. This not only minimizes risks and costs associated with early clinical trials but also provides invaluable insights into treatment efficacy and safety.

Designing the Future of Medicine

But wait, there’s more! Digital Twins don’t just stop at predicting outcomes; they’re also the architects of tomorrow’s medical interventions. By guiding research with precision and foresight, Digital Twins enhance the design and development of treatments, paving the way for a future where medical breakthroughs are consistently reliable.

So, there you have it – a glimpse into the world of preclinical predictions powered by Digital Twins. From minimizing risks and costs to providing insights and shaping the future of medicine, Digital Twins are the ultimate sidekick in the quest for safer, more effective treatments.

So, the next time you’re faced with the daunting task of preclinical testing, remember: before the trial, there’s a Digital Twin waiting to light the way.

Quality Assurance at the Speed of Innovation: Kubernetes in Drug Development

Veritas Automata Akshay Sood

Akshay Sood

Veritas Automata Fabrizio Sgura

Fabrizio Sgura

Veritas Automata David Ayala

David Ayala

In the busting arena of drug development, where every moment counts and breakthroughs are the currency of progress, a burning question looms: How do we maintain quality assurance standards at the breakneck speed demanded by innovation?

The average time from drug discovery to market approval spans a daunting 10 to 15 years, with only a fraction of compounds making it through the rigorous testing gauntlet. Meanwhile, the pressure to innovate and deliver life-saving treatments mounts daily, leaving little room for error or delay.

Rancher K3s Kubernetes emerges as a game-changer in the race against time, serving as the central component of a revolution in drug development. Here, quality assurance converges with the lightning speed of innovation.

Speeding Up the Assembly Line: GitOps in Action

Imagine a scenario where computational drug models are developed, tested, and deployed at a pace that matches the frenetic beat of discovery. Rancher K3s Kubernetes, coupled with GitOps principles, makes this a reality. With GitOps, changes to infrastructure and application configuration are managed as code, ensuring rapid, reliable deployment of computational resources with minimal human intervention.

Quality Assurance on Overdrive: Digital Twins at the Helm

In a scenario where Digital Twins, mirroring physical assets, stand as sentinels of quality assurance in drug development, Rancher K3s Kubernetes facilitates the generation and oversight of these Digital Twins. This enables ongoing monitoring and testing of drug models within a simulated environment. This proactive strategy ensures early identification and resolution of potential issues, mitigating the risk of significant setbacks as development progresses.

Rancher K3s Kubernetes isn’t just another tool in the arsenal of drug developers, it’s a catalyst for change—a force multiplier that empowers teams to push the boundaries of innovation while maintaining uncompromising quality standards.

By embracing the principles of GitOps and harnessing the power of Digital Twins, we can revolutionize the drug development process, bringing life-saving treatments to market faster and more efficiently than ever before. The time for quality assurance at the speed of innovation is now.

OTA Updates: A New Frontier in Medical Device Management

Veritas Automata Fabrizio Sgura

Fabrizio Sgura

Chief Engineer

Veritas Automata Anusha Kotla

Anusha Kotla

Staff Engineer

When it comes to healthcare, where innovation is both a beacon of hope and a catalyst for change, how do we ensure that our medical devices remain at the forefront of technology, without compromising security or regulatory compliance?

The global medical device market is projected to reach over $950 billion by 2027[1], driven by the increasing prevalence of chronic diseases and the demand for advanced treatment options. Despite this exponential growth, traditional methods of device management often fall short in keeping pace with the rapid advancements in technology.

Unveiling OTA Updates

Over-The-Air (OTA) updates are a new frontier in medical device management, revolutionizing the way we maintain and optimize our medical devices. With OTA updates via Mender, healthcare providers can ensure that their devices are always up-to-date with the latest software, without the need for costly and time-consuming manual interventions.

Navigating Security and Compliance Challenges

But let’s not overlook the elephant in the room: security and regulatory compliance. In an era where cyber threats loom large and regulatory standards are constantly evolving, ensuring the security and compliance of medical devices is imperative. With robust cybersecurity measures in place, including encryption protocols and authentication mechanisms, OTA updates can address these challenges head-on, providing a secure and efficient means of device management.

Facilitating Remote Diagnostics and Maintenance

Beyond software updates, OTA technology opens the door to a world of possibilities in remote diagnostics and maintenance. Imagine a scenario where healthcare providers can remotely diagnose issues, troubleshoot problems, and perform maintenance tasks—all without the need for in-person visits or costly equipment recalls. This proactive approach not only enhances patient care but also reduces downtime and costs associated with device maintenance.

Realizing the Potential

Consider the case of a hospital system grappling with the challenge of managing a fleet of medical devices spread across multiple facilities. By implementing OTA updates via Mender and leveraging advanced cybersecurity measures, the hospital system can streamline device management, ensuring compliance with regulatory standards and reducing the risk of cyber threats. The result? Improved patient outcomes, increased operational efficiency, and significant cost savings.

Embracing the Future of Healthcare

OTA updates represent a transformation in medical device management—a shift towards a future where devices are always up-to-date, secure, and compliant. By embracing this technology and implementing robust cybersecurity measures, healthcare providers can unlock new levels of efficiency, safety, and innovation in patient care.
The time to embrace OTA updates for medical device management is now. Are you ready to join the revolution with Veritas Automata?

Next-Gen Pharma: Blockchain-Driven Autonomous Transactions in Life Sciences

Veritas Automata Akshay Sood

Akshay Sood

Sr. Blockchain Consultant

Veritas Automata Rodolfo

Rodolfo Leal

Director, Software Engineering

Veritas Automata Fabrizio Sgura

Fabrizio Sgura

Chief Engineer

In the competitive arena of life sciences, where progress is both a currency and a necessity, a disruptor has emerged, armed with digital muscle: blockchain technology.

But let’s cut to the chase. Why, in an age of rapid advancement, does an industry as vital as life sciences still grapple with outdated processes, drowning in paperwork and inefficiencies while the world marches forward?
Despite the brilliant minds and groundbreaking research, a whopping 80% [1] of clinical trials struggle to meet their enrollment deadlines. Moreover, navigating the labyrinth of regulatory compliance often feels akin to tiptoeing through a minefield, with missteps resulting in financial fiascos and patient peril.

No Frills, Just Facts

Enter blockchain, a bold solution and the disruptor-in-chief of legacy systems. Picture a decentralized ledger where every transaction, every data point, is recorded securely and immutably, accessible only to authorized parties, orchestrated by Smart Contracts. They execute flawlessly, no hand-holding required. And supply chains? They’re transparent and bulletproof; traceability is the nature of the technology. Bolstered by transparency, no repudiation of transactions agreed between parts will grant the same trust as signed deals.

Skeptics Will Scoff

But hey, we’re not naive. Scalability? We’ve got it covered. Interoperability? Consider it done. Regulatory concerns? We’re at the table, shaping the rules.
Harnessing the power of technologies like Rancher K3s Kubernetes, we’re paving the way for scalable, easy to integrate blockchain solutions tailored to the unique needs of the life sciences industry. We’re collaborating with regulatory bodies to establish frameworks that strike the delicate balance between innovation and compliance, ensuring that patient safety remains paramount.
The era of blockchain-driven autonomy in life sciences isn’t a pipe dream, it’s our reality. As we navigate the uncharted waters of technological innovation, let’s embrace the transformative potential of blockchain and smart contracts to usher in a new era of efficiency, transparency, and integrity.
So buckle up, because we’re not just talking change, we’re making it happen. The time for Next-Gen Pharma is now. Join us in revolutionizing the future of life sciences.

Streamlining Clinical Trial Data: Overcoming Performance Testing Challenges

Veritas Automata Mauricio Arroyave

Mauricio Arroyave

Client Overview and Challenge
A key player’s goal, in the clinical trial data industry, was to consolidate all clinical trial data on a unified platform.
The client faced the challenge of modifying their application, which was implemented using .NET libraries, to accommodate performance testing. These libraries had become deprecated and needed to be replaced. The client required a solution that was both easy to implement and maintain, and was flexible enough to adapt to future challenges.
Technologies Used:
Solution:

Veritas Automata presented three different options to the client for addressing their performance testing needs, which included Gatling, K6, and JMeter. After a thorough evaluation, JMeter was chosen. Yuxi Global then created 11 scenarios, designed to test the application’s performance under different capacity conditions. JMeter’s multiple post-processors and plugins were utilized to generate results in various formats, such as charts, plain text, or CSV files for more comprehensive reporting.
Client Satisfaction and Testimonial
“Generally, I am wary of putting my trust fully in an outsource partner, especially for a complete function like testing. As a software vendor, it’s critical to ensure that your product is effectively tested before rolling it out to your clients; missed bugs or issues can drastically impact the trust your customers have in you and your overall reputation. Working with Veritas Automata has alleviated those fears. From the first day we engaged both the team and the management, they have been both professional and diligent in managing our software testing as if it is their own product.

Navigating Technological Evolution: Healthcare IT and Clinical Research Platform Enhancement

Veritas Automata Brian Tafur

Brian Tafur

Veritas Automata Duvan Hurtado

Duvan Hurtado

Client Overview

A provider of biopharmaceutical development, consulting and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including strategy and management consulting services

Client Challenge:

The healthcare IT company’s comprehensive and accurate benchmarking tool allows sponsors and contract research organizations to confidently forecast and budget investigator grant costs electronically. It uniquely combines all industry data sources, delivering Fair Market Value itemized costs that facilitate global forecasting and budgeting across various study phases and therapeutic areas. The client’s application was initially built in JavaScript HTML and .NET, and they were eager to enhance the application’s loading speed and overall efficiency. This project had several objectives:

Solution:

The collaboration journey is far from over. The plan for the future includes continuing the migration until 100% of the front end is on Angular. Veritas Automata remains committed to optimizing application performance, demonstrating an enduring dedication to the client’s success.

Technologies Used
Client testimonials:
“Our products are technically undergoing constant enhancements, constant technical improvements in order to serve our clients so it’s critical for us to have a group like Veritas Automata partner with us to service our needs.“

“With a trusted partnership spanning nearly 13 years, the strong relationship, built on expertise and reliability, continues to be the fundament of this collaboration.“

Integrating strategic technologies and methodologies revolutionize Life Sciences operations

Veritas Automata Daniel Misas

Daniel Misas

Veritas Automata Pablo Diaz

Pablo Diaz

Client Challenge
The life science laboratories faced fierce competition in a rapidly evolving market, compounded by the struggle to hire technical talent quickly. They required a technology force multiplier to accelerate their development pace, surmount technical obstacles, and remain competitive.
Slow hiring of developers hindered their capacity to handle business demands. The life science labs company’s manual process based in Excel files led to error-prone scenarios, impeded competitiveness, and prevented scaling, leading to increased prices for sample tests. The laboratories needed to automate various aspects of their operations to improve accuracy, efficiency, and competitiveness in the market.
Technologies Used
Yuxi Global leveraged a range of advanced technologies to automate the laboratories’ processes. These technologies include:

Azure DevOps: Used for requirement tracking, CI/CD pipelines setup, version control, and automated unit testing.

React JS: Employed to develop Single Page Applications (SPAs) for each Life Science’s Lab project.

Microsoft SQL Server: Utilized as the project database.

Internet Information Services: Web servers used to expose the software users are consuming via their browsers.

C# and ASP.Net Core: Employed for backend logic and development.

Azure Service Bus: Facilitated communication between microservices.

Azure Application Insights: For monitoring and logging web app errors and warnings.

K6.io: Utilized for load testing to simulate real-world usage scenarios.

Domain Driven Design: Applied to encapsulate domain logic and improve software design.

Veritas Automata solution
The Life Science laboratories achieved significant improvements by automating several of their systems. Automation led to: reduced sample test/analysis prices, enhancing competitiveness in the market; streamlined operations, reduced errors, and increased efficiency; and enabled the life science labs to scale its operations seamlessly, accommodating a growing customer base to improve profitability without sacrificing accuracy.
Need help optimizing your Life Science operations? Skip the sales team and speak to the experts directly.